Athersys, Inc. Banner Image

Athersys, Inc.

  • Ticker ATHX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Athersys, Inc. Logo Image
  • 51-200 Employees
  • Based in Cleveland, Ohio
Athersys is an international biotechnology company engaged in the development of therapeutic products designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune diseaseMore areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance MultiStem cell therapy toward commercialization.
4.8 / 5.0 (222)

Athersys, Inc. reports have an aggregate usefulness score of 4.8 based on 222 reviews.

Athersys, Inc.

Most Recent Annual Report

Athersys, Inc.
MOST RECENT 2022 Annual Report and Form 10K
Add Annual Report To Cart

Older/Archived Annual Reports

Athersys, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!